Clinical Trial Materials

Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Clinical Trial Materials | Industry News

Catalent Plans $100M Expansion of Biologics Mfg. Capabilities in Italy

Initial phase includes installation of two 2,000-liter single-use bioreactors and associated investments to support early-and late-phase clinical development.

07.21.21

Vetter’s New Clinical Mfg. Site Now Fully Integrated

Expands clinical capacity to address growing market demand.

07.21.21

Breaking News | cGMP Manufacture | Clinical Trial Materials | Facilities | Industry News

ImmVira Launches Pilot-scale Production Line

To expedite the advancement of next-generation oncolytic virus clinical trials.

07.20.21

Samsung Biologics, Kineta Enter Development and Manufacturing Agreement

Samsung's San Francisco R&D center and South Korea headquarters to offer end-to-end CDMO service for anti-VISTA antibody immunotherapy.

07.20.21

Curtana and Catalent Enter Brain Cancer Drug Partnership

Sign development and manufacturing agreement for brain cancer drug CT-179.

07.16.21

Bio News | Biologics, Proteins, Vaccines | Breaking News | Clinical Trial Materials | Industry News

GentiBio, Forge Biologics Ink Development and Manufacturing Agreement

Partnership to support GentiBio’s cell therapy pipeline with AAV process development, scale up and GMP manufacturing services.

07.16.21

Batavia Manufactures IAVI’s Lassa Fever Vax Candidate

Uses innovative 'scale-X' bioreactor to support Phase I clinical trials.

07.14.21

Batavia to Develop Clinical Process for RocketVax’s COVID-19 Vaccine

After successful completion, Batavia will continue to scale-up and optimize the process for commercial scale.

07.08.21

Cobra Biologics, CombiGene Ready to Start GMP Production of Epilepsy Drug Candidate

Complete production and quality assurance of the plasmids to be used in the GMP production of CG01.

06.25.21

Breaking News | Clinical Trial Materials

Chemomab and AGC Biologics Partner to Manufacture CM-101 for Phase II/III

AGC Biologics will manufacture the clinical trial materials at its site in Copenhagen to support clinical testing and launch readiness.

06.24.21

Breaking News | Clinical Trial Materials | Industry News

CaroGen, BioCentriq Enter Clinical Manufacturing Pact

BioCentriq to provide clinical manufacturing to support Phase 1 clinical trials of CaroGen's lead immunotherapy candidate, CARG-201.

06.22.21

Clinical Trial Materials | Cold Chain Management | Logistics | Supply Chain

Mitigating the Logistical Challenges Associated with Clinical Studies of Investigational Drugs

How Sentry BioPharma Services supports clinical studies with just-in-time custom labeling/kitting/packaging and more.

Sponsored released by Sentry BioPharma Services 06.17.21

Enteris BioPharma Receives $10M Milestone from Cara Therapeutics

Third milestone payment related to the development of Oral KORSUVA.

06.11.21

Revolo and Northway Biotech Enter Manufacturing Partnership

To manufacture novel binding immunoglobulin protein, ‘1805, to support phase 2 trials in rheumatoid arthritis and uveitis.

06.11.21

Yourway Breaks Ground on Major Expansion at Pennsylvania HQ

The project includes a new Phase I clinical trials unit.

06.09.21

Clinical Trial Materials | Drug Development | Preclinical Outsourcing

Strategies for Entering Phase 1 Clinical Development with Limited API

Removing API supply as a criterion in the “Go/No-Go” decision tree and enhancing the opportunity to successfully navigate the pharmaceutical “Valley of Death.”

Thomas Daggs and Angelo Consalvo, Enteris BioPharma 06.07.21

Breaking News | cGMP Manufacture | Clinical Trial Materials | Industry News